Efficacy of recombinant human soluble thrombomodulin in severe postpartum hemorrhage with disseminated intravascular coagulation

Clinical and Applied Thrombosis/Hemostasis

Volumn 19, Issue 5, 2013, Pages 557-561

  Sugawara, Junichi ^a   Suenaga, Kaori ^a   Hoshiai, Tetsuro ^a   Sato, Takahiro ^a   Nishigori, Hidekazu ^a   Nagase, Satoru ^a   Yaegashi, Nobuo ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

anticoagulants; bleeding; gynecology and obstetrics

Indexed keywords

ANTITHROMBIN; D DIMER; FIBRINOGEN; FRUCTOSE BISPHOSPHATE; HEMOGLOBIN; RECOMBINANT THROMBOMODULIN;

ADULT; ARTICLE; BLEEDING; BLOOD CLOTTING; BLOOD TRANSFUSION; CESAREAN SECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG EFFICACY; FEMALE; HUMAN; HYSTERECTOMY; INCIDENCE; MALE; MEDICAL RECORD REVIEW; OBSERVATIONAL STUDY; OBSTETRIC PATIENT; PARTIAL THROMBOPLASTIN TIME; PLACENTA ACCRETA; PLACENTA PREVIA; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; PROTHROMBIN TIME; SHOCK; SOLUTIO PLACENTAE; THROMBOCYTE COUNT;

ANTICOAGULANTS; BLEEDING; GYNECOLOGY AND OBSTETRICS;

ADULT; DISSEMINATED INTRAVASCULAR COAGULATION; FEMALE; HUMANS; POSTPARTUM HEMORRHAGE; PREGNANCY; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; THROMBOMODULIN;

EID: 84880451145     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/1076029612443305     Document Type: Article

References (16)

1. Khan K, Wojdyla D, Gulmezoglu A, Van Look P. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006 ; 376 (9516). 1066-1074
2. Kanayama N, Inori J, Ishibashi-Ueda H, et al. Maternal death analysis from the Japanese autopsy registry for recent 16 years: significance of amniotic fluid embolism. J Obstet Gynecol Res. 2011 ; 37 (1). 58-63
3. Levi M, Toh CH, Thachil J, Watson HG. Guidelines for the diagnosis and management of disseminated intravascular coagulation. Br J Haematol. 2009 ; 145 (1). 24-33
4. Maruyama I. Recombinant thrombomodulin and activated protein C in the treatment of disseminated intravascular coagulation. Thromb Haemost. 1999 ; 82 (2). 718-721
5. Saito H, Maruyama S, Shimazaki Y, et al. Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial. J Thrombo Haemost. 2006 ; 5 (1). 31-41
6. Ikezoe T, Togitani K, Komatsu N, Isaka M, Yokoyama A. Successful treatment of sinusoidal obstructive syndrome after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin. Bone Marrow Transplant. 2010 ; 45 (4). 783-785
7. Yamakawa K, Fujimi S, Mohri T, et al. Treatment effects of recombinant human soluble thrombomodulin in patients with severe sepsis: a historical control study. Crit Care. 2011 ; 15 (3). R123
8. Ikezoe T, Ikenoue N, Uchikawa N, Kojima S, Fukaya T, Yokoyama A. Use of recombinant human soluble thrombomodulin in the management of HELLP syndrome complicated by DIC. Thromb Res. 2010 ; 126 (3). e238 - e240
9. Postpartum Hemorrhage. Obstet Gynecol. 2006 ; 108 (4). 1039-1048
10. Taylor FB, Toh CH, Hoots WK, et al. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001 ; 86 (5). 1327-1330
11. Aibiki M, Fukuoka N, Umakoshi K, Ohtubo S, Kikuchi S. Serum albumin levels anticipate antithrombin III activities before and after antithrombin III agent in critical patients with disseminated intravascular coagulation. Shock. 2007 ; 27 (2). 139-144
12. KobayashiNMaekawaTTakadaMTanakaHGonmoriH. Criteria for diagnosis of DIC based on the analysis of clinical and laboratory findings in 345 DIC patients collected by the research committee on DIC in Japan. Bibl Haematol. 1983;(49):265-75http://www.ncbi.nlm.nih.gov/pubmed/6667250.
13. Schuepbach RA, Feistritzer C, Fernandez JA, Griffin JH, Riewald M. Protection of vascular barrier integrity by activated protein C in murine models depends on protease-activated receptor-1. Thromb Haemost. 2009 ; 101 (4). 724-733
14. Abeyama K, Stern DM, Ito Y, et al. The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel anti-inflammatory mechanism. J Clin Invest. 2005 ; 115 (5). 1267-1274
15. Kobayashi T, Terao T, Maki M, Ikenoue T. Diagnosis and management of acute obstetrical DIC. Semin Thromb Hemost. 2001 ; 27 (2). 161-168
16. Tsubokura M, Yamashita T, Inagaki L, et al. Fatal intracranial hemorrhage following administration of recombinant thrombomodulin in a patient after cord blood transplantation. Bone Marrow Transplant. 2011 ; 26 (7). 1030-1031